Viramune (Nevirapine) – Patient Information (UK)

Viramune is a brand of nevirapine, an antiretroviral medicine used to treat HIV-1 infection. This page explains how Viramune works, how it is taken, common interactions, and important safety information to help you use the medicine more confidently.

Important: HIV treatment is usually a combination approach. Viramune is typically taken alongside other HIV medicines to achieve the best results.

Quick overview

• Active ingredient: Nevirapine
• Medicine type: Non-nucleoside reverse transcriptase inhibitor (NNRTI)
• Common uses: Treatment of HIV-1 infection as part of combination antiretroviral therapy
• How it’s taken: Usually by mouth, once daily then increasing to twice daily (depending on local prescribing plan)
• Key safety considerations: Risk of liver problems and serious skin reactions, especially during the first weeks of treatment
• UK availability: Typically supplied via UK pharmacies under regulated medicines supply chains

What is Viramune?

Viramune contains the antiviral medicine nevirapine. It belongs to a group called NNRTIs (non-nucleoside reverse transcriptase inhibitors). NNRTIs work by blocking an HIV enzyme that the virus needs to multiply.

Nevirapine has been used for many years in HIV care. In the UK, it has been prescribed in combination regimens based on clinical factors such as previous treatment history, resistance patterns, pregnancy considerations (where applicable), and tolerability.

How Viramune works (mechanism of action)

To reproduce, HIV relies on an enzyme called reverse transcriptase. This enzyme converts HIV’s genetic material from RNA into DNA so the virus can replicate inside human cells.

Nevirapine works by:

• Binding to reverse transcriptase at a site different from nucleoside medicines
• Blocking the enzyme’s activity, preventing HIV from making viral DNA
• Reducing viral replication, helping lower the amount of HIV in the blood (viral load)

Because resistance can develop if one drug is used alone, Viramune is generally used as part of combination antiretroviral therapy.

Pharmacokinetics: how the body handles nevirapine

Pharmacokinetics describes how a drug is absorbed, distributed, metabolised, and eliminated.

• Absorption: Nevirapine is taken by mouth and absorbed into the bloodstream.
• Distribution: It distributes through body tissues, including areas relevant to HIV infection.
• Metabolism: Nevirapine is primarily metabolised by the liver.
• Elimination: It is cleared from the body mainly through metabolism and subsequent excretion of breakdown products.
• Half-life: Nevirapine has a relatively long half-life compared with many other HIV medicines, which contributes to its dosing strategy. (Your prescriber will specify the exact schedule for your situation.)

Because nevirapine is processed largely by the liver, people with liver disease or elevated liver enzymes need extra caution and monitoring.

Typical use in the UK

Viramune is used to manage HIV-1 infection. It is usually prescribed within a combination regimen that may include medicines from other drug classes. The choice of regimen depends on:

• Your current viral load and CD4 cell count
• Prior HIV treatment history
• Any known resistance results
• Co-existing health conditions (especially liver disease)
• Other medicines you take (to manage drug interactions)
• Pregnancy status (where relevant) and overall treatment goals

In the UK, HIV treatment is guided by national and specialist clinical recommendations and by assessment from trained HIV services.

Indications (when Viramune is used)

Nevirapine is indicated for:

• HIV-1 infection in adults and in some circumstances other populations, as part of combination antiretroviral therapy.

Your treatment plan should be based on current HIV specialist advice and your individual clinical needs.

Dosing and timing: what to expect

It is essential to follow the specific dosing instructions provided by your healthcare professional and those on the pharmacy label.

In many established regimens, nevirapine is started at a lower dose for a lead-in period to reduce the risk of early side effects (particularly skin and liver reactions). After this lead-in, the dose is typically increased.

Common dosing pattern (general example)

• Weeks 1–2: Lower dose once daily (or as directed)
• After lead-in: Increased to the maintenance dose (often twice daily, depending on the formulation and plan)

Do not change the dose or skip the lead-in period unless your clinician specifically instructs you. Stopping and restarting can require reassessment of risks.

Timing tips

• Take your doses at consistent times each day.
• If you miss a dose, check the advice on the label or contact a healthcare professional/pharmacist for guidance.
• Try to avoid taking doses at irregular intervals, as this may affect viral control.
• For twice-daily regimens, aim for roughly 12 hours apart.

Food interactions and taking with meals

Nevirapine can generally be taken with or without food. However, individual absorption and comfort may vary.

Practical guidance:

• If Viramune upsets your stomach, consider taking it with food.
• Maintain a consistent routine to reduce variability.
• Always follow the instructions on your medicine label.

Note: Food is not usually the biggest interaction concern for nevirapine—rather, medicines that affect liver enzymes or drug metabolism are often more significant.

Alcohol and medicine interactions

Alcohol

Because nevirapine is processed in the liver, drinking alcohol may increase the burden on the liver and could raise the risk of liver-related side effects.

Patient-friendly advice:

• If you drink alcohol, consider keeping it to a minimum and avoid binge drinking.
• If you have hepatitis, fatty liver disease, or previously elevated liver enzymes, discuss alcohol use with your clinician.
• Stop alcohol and seek urgent medical advice if you develop symptoms of liver problems (see the safety section).

Medicine interactions (especially important)

Nevirapine is known to interact with medicines that influence liver enzyme systems. Some interactions can lower Viramune levels (reducing effectiveness) or increase the risk of side effects.

Tell your pharmacist or clinician about all medicines you take, including:

• Prescription HIV and non-HIV medicines
• Over-the-counter products (e.g., pain relief, cold remedies)
• Herbal products (e.g., St John’s wort)
• Supplements
• Vitamins

Common categories of interacting medicines include:

• Rifampicin and rifabutin (TB medicines) – may reduce nevirapine levels
• Some anticonvulsants (e.g., carbamazepine, phenytoin, phenobarbital) – may reduce effectiveness
• St John’s wort (Hypericum perforatum) – can significantly reduce levels and should generally be avoided
• Oral hormonal contraceptives – may be affected; additional contraception may be needed
• Antacids or acid-reducing medicines – may affect absorption for some people (discuss individual options)
• Other medicines affecting the liver – may increase the risk of liver problems

This is not a complete list. Interactions can vary by dose and by the exact regimen you are using.

Safety profile: important warnings

Most people tolerate nevirapine, but some serious side effects require urgent attention. The highest risk period is usually the first several weeks after starting or restarting Viramune.

Seek urgent medical help immediately if you develop any of the following:

• Signs of serious skin reactions: widespread rash, blistering, peeling skin, mouth ulcers, or rash with fever
• Symptoms of liver problems: yellowing of the skin or eyes (jaundice), dark urine, severe tiredness, nausea/vomiting, upper abdominal pain, or unusual itching
• Allergic reactions: swelling of face/lips, breathing difficulty, or severe dizziness

Liver-related side effects

Nevirapine can cause elevations in liver enzymes and, in rare cases, severe hepatitis. Risk may be higher in certain groups.

Typical monitoring may include:

• Baseline liver function tests
• Follow-up blood tests early after starting
• Additional tests if symptoms occur

Skin reactions

Rash is one of the most commonly reported side effects. Some rashes are mild, but others can be severe. Any rash during the early phase should be assessed promptly.

Other possible side effects

• Headache
• Nausea
• Fatigue
• Generalised rash or skin changes
• Changes in laboratory values (including liver tests)

If side effects occur, contact your healthcare team promptly—especially during the first weeks.

Practical use tips (how to stay on track safely)

• Use a dose routine: Link doses to daily routines (e.g., breakfast and evening meal).
• Attend monitoring appointments: Blood tests and early follow-up are critical with nevirapine.
• Do not restart on your own: If you stop for any reason and are considering restarting, speak to a clinician first—restarting may require special precautions.
• Check your medicines: Keep an up-to-date list of everything you take and show it to your pharmacist.
• Avoid St John’s wort: It can significantly reduce effectiveness.
• Know the warning signs: Be alert for rash, jaundice, or severe tiredness—contact healthcare services quickly if these appear.

Alternative options

Many medicines can be used to treat HIV depending on your needs and resistance profile. If Viramune is not suitable due to side effects, interactions, or treatment goals, your HIV specialist may consider alternatives such as:

Other NNRTIs (examples)

• Efavirenz
• Rilpivirine
• Dolutegravir-based regimens (note: dolutegravir is an integrase inhibitor, not an NNRTI)

Commonly used modern backbone options (examples)

• Integrase inhibitors (often used in contemporary regimens)
• Two-nucleoside “backbones” combined with an integrase inhibitor or other class

Important: Which alternative is appropriate depends on your personal history, viral resistance, other health conditions, and potential drug interactions. Your clinician will guide you.

UK market and legal context

In the United Kingdom, medicines such as Viramune are regulated through the Medicines and Healthcare products Regulatory Agency (MHRA) and supplied under established standards for safety, quality, and traceability.

HIV medicines are typically dispensed through regulated pharmacy channels, and patients are often supported by specialist HIV services. Pharmacy supply may vary depending on local commissioning, stock availability, and treatment protocols.

Healthcare professionals in the UK follow evidence-based guidance from recognised bodies, including clinical guidelines produced for HIV care.

Recent guidance and considerations (UK/EU context)

Clinical recommendations for HIV treatment can evolve as new evidence and new medicines become available. Ongoing themes in UK HIV care include:

• Using combination therapy with careful selection to maintain viral suppression.
• Resistance assessment where relevant (especially if switching treatments).
• Safety monitoring for medicines with known risks (including liver and skin monitoring for nevirapine).
• Drug–drug interaction review as a standard part of care.

Your clinician may decide whether nevirapine remains the best choice for your individual circumstances. If you are already taking Viramune successfully, changes should only be made with medical guidance.

Delivery and availability in the UK

Availability can vary depending on the specific strength and formulation required. Online pharmacies that operate lawfully in the UK may supply Viramune subject to stock, regulatory requirements, and prescription/dispensing pathways where applicable.

What you can generally expect when ordering:

• Secure packaging to protect the product during transit
• Clear labelling with directions and batch/expiry information
• Dispatch timing dependent on stock and cut-off times
• Trackable delivery may be available

If the medicine is out of stock, reputable pharmacies often provide alternative options (such as another supplier or equivalent formulation) or notify you of expected delivery times.

Table: Key facts at a glance

FAQ

1) Is Viramune used alone for HIV?

No. Viramune (nevirapine) is generally used as part of combination antiretroviral therapy. Using only one medicine can lead to resistance and treatment failure.

2) How soon will Viramune start working?

Many people see decreases in viral load after starting effective combination therapy, but the timing varies. Your HIV clinic will monitor your viral load and CD4 count to check how well treatment is working.

3) What should I do if I miss a dose?

If you miss a dose, follow the instructions on your medicine label or contact your pharmacist/clinic for guidance. Avoid taking double doses unless specifically advised.

4) Can I take Viramune with food?

Yes, Viramune is usually taken with or without food. If it upsets your stomach, taking it with food may help. Keep a consistent routine.

5) Why is there a lower dose at the beginning?

Many regimens start with a lead-in period to reduce the risk of early side effects, particularly skin reactions and liver problems.

6) What symptoms mean I should seek urgent medical help?

Seek urgent advice if you develop severe or widespread rash, blistering/peeling skin, mouth sores with fever, or signs of liver problems such as jaundice, dark urine, severe tiredness, or upper abdominal pain.

7) Can I drink alcohol while taking Viramune?

You should use caution. Nevirapine is processed by the liver, so heavy alcohol intake could increase risk of liver-related side effects. If you choose to drink, keep it minimal and avoid binge drinking. Discuss your situation with your clinician, especially if you have liver disease.

8) Are there medicines or supplements I must avoid?

Yes—some interactions can be significant. In particular, St John’s wort is generally avoided because it may reduce effectiveness. Also check with your pharmacist before starting or stopping any medicine, including TB medicines, anticonvulsants, and hormonal contraception.

9) Does Viramune affect contraception?

Some hormonal methods may be less reliable due to interactions. If you use contraception, ask your clinician or pharmacist about the most suitable method for you.

10) Where can I get Viramune in the UK?

Viramune is supplied through regulated UK pharmacy channels subject to stock and dispensing processes. Online pharmacies typically dispatch once verified and processed according to UK medicines regulations.

Need more help? If you have questions about taking Viramune, interactions, or side effects, speak to a pharmacist or your HIV clinic. Early advice is especially important if you develop a rash or symptoms that could suggest liver problems.